CG
PCRX icon

Cutler Group’s Pacira BioSciences PCRX Stock Holding History

Cutler Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$5K – 5345
2022
Q2 		$5K Buy
+100
New +$6.55K ﹤0.01% 3739
2019
Q2 		– Sell
-1,000
Closed -$42.5K – 4654
2019
Q1 		$38K Buy
+1,000
New +$39K ﹤0.01% 1612
2018
Q2 		– Sell
-2,700
Closed -$84K – 4687
2018
Q1 		$84K Sell
2,700
-5,193
-66% -$185K 0.01% 1307
2017
Q4 		$360K Sell
7,893
-3,640
-32% -$144K 0.01% 680
2017
Q3 		$433K Buy
11,533
+9,957
+632% +$401K 0.02% 727
2017
Q2 		$75K Sell
1,576
-8,541
-84% -$396K ﹤0.01% 2107
2017
Q1 		$461K Sell
10,117
-12,523
-55% -$541K 0.02% 680
2016
Q4 		$731K Buy
22,640
+7,780
+52% +$260K 0.03% 528
2016
Q3 		$508K Buy
+14,860
New +$582K 0.02% 597
2016
Q2 		– Sell
-1,956
Closed -$96.1K – 7118
2016
Q1 		$103K Sell
1,956
-3,885
-67% -$227K 0.01% 1584
2015
Q4 		$448K Buy
+5,841
New +$331K 0.03% 676

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return